Status:
TERMINATED
Selenium Supplementation of Patients With Cirrhosis
Lead Sponsor:
Vanderbilt University
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Liver Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether patients with liver cirrhosis can improve their selenium nutritional status by taking supplemental selenium.
Detailed Description
Selenium is an essential nutrient. Selenium carries out its biological functions through selenoproteins. The liver converts dietary selenium to a form that can be used to make selenoproteins. Patients...
Eligibility Criteria
Inclusion
- liver disease
- aged 18 or above
Exclusion
- substance abuse
- renal failure
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT00271245
Start Date
February 1 2006
End Date
March 1 2012
Last Update
March 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232